Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Filters applied. Clear all
. 2013 May 6;6:29-34.
eCollection 2013.

The Determinants of Translational Medicine Success - A Managerial Contribution

Affiliations
Free PMC article

The Determinants of Translational Medicine Success - A Managerial Contribution

Francesco Polese et al. Transl Med UniSa. .
Free PMC article

Abstract

Scope of Translational Medicine is to speed the development of new compounds of medical protocols and/or treatments to improve patient's quality of life. Translational medicine represents the synergy between epidemiology, basic research and clinical trials, and is based upon Innovation Management and Research Development in medicine. Being the speed and progression up to the patient a key issue of Translational Medicine, the innovation process ought to be pursued according to rigorous protocols embedded on a research development path capable of decreasing the lead time at the most. Translational Medicine represents a goal to be pursued by all involved actors, from academic researchers to clinicians, patients and others than can be seen as a network of co-creating actors engaged for the ultimate patient benefit. To underpin Translational Medicine advantages and determinants, the paper approaches the issue by adopting a systems thinking perspective, capable of highlighting the key issues to be considered.

Keywords: Translational medicine; health networks; innovation management; service co-creation; systems thinking.

Similar articles

See all similar articles

Cited by 1 article

References

    1. Wang X . A new vision of definition, commentary, and understanding in clinical and translational medicine . Clinical and Translational Medicine . 2012 ; 1 : 1:5 . - PMC - PubMed
    1. Olson S , Claiborne AB . Strengthening a Workforce for Innovative Regulatory Science in Therapeutics Development . The National Academies Press ; Washington : 2012 .
    1. Hutton J . Transforming Translation – Harnessing Discovery for Patient and Public Benefit . US : 2007 . Report of the Translational Research Working Group of the National Cancer Advisory Board .
    1. Anastasio A , Armenante A , Gimigliano A , Moscarino A , Panzera S , Romano R , Russo I , Scarpati G . To be on not to be Translational . Translational Medicine . 2013 ; 5 ( 3 ): 5 – 6 . - PMC - PubMed
    1. Littman BH , Di Mario L , Plebani M , Marincola FM . What’s next in translational medicine? . Clinical Science . 2007 ; 112 : 217 – 227 . - PubMed

LinkOut - more resources

Feedback